Literature DB >> 4123535

Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?

C O'Toole, P Perlmann, H Wigzell, B Unsgaard, C G Zetterlund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4123535     DOI： 10.1016/s0140-6736(73)90396-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Fibrinolytic activity of in vitro cultivated human bladder cell lines.

Authors:  H Hisazumi; L Andersson; V P Collins
Journal:  Urol Res       Date:  1977

2.  The lymphocyte plasma membrane: locus of control in the immune response.

Authors:  L M Jerry; A K Sullivan
Journal:  In Vitro       Date:  1976-03

3.  Identification of lymphocyte subpopulations in E-RFC-enriched and E-RFC-depleted cell fractions of fresh and cryopreserved lymphocytes.

Authors:  R L Bolhuis; H R Schuit
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

Review 4.  Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.

Authors:  J Bubeník
Journal:  Int Urol Nephrol       Date:  1975       Impact factor: 2.370

5.  Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.

Authors:  A H Greenberg; L Shen; G Medley
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

6.  Tumour markers in urology: aids in cancer diagnosis and management.

Authors:  B Wahren
Journal:  Urol Res       Date:  1979-06-22

7.  Mechanisms of corticosteroid action on lymphocyte subpopulations. III. Differential effects of dexamethasone administration on subpopulations of effector cells mediating cellular cytotoxicity in man.

Authors:  J E Parrillo; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

8.  Characteristics of complexes for arming and inhibiting effector cells for antibody-dependent cell-mediated cytotoxicity.

Authors:  L Walker; F C Hay; I M Roitt
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

9.  [Humoral immune response--cervical cancer patients: lymphocytotoxic antibodies (author's transl)].

Authors:  U D Koenig; N Müller
Journal:  Arch Gynakol       Date:  1978-10-18

10.  [The lymphocyte cytotoxicity test in tumor immunology (author's transl)].

Authors:  H W Pees
Journal:  Klin Wochenschr       Date:  1975-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.